# An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine

> **NCT06484686** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Sinovac (Dalian) Vaccine Technology Co., Ltd.** · enrollment: 414 (estimated)

## Conditions studied

- Varicella

## Interventions

- **BIOLOGICAL:** Live Attenuated Varicella Vaccine

## Key facts

- **NCT ID:** NCT06484686
- **Lead sponsor:** Sinovac (Dalian) Vaccine Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-09-16
- **Primary completion:** 2028-12
- **Final completion:** 2031-12
- **Target enrollment:** 414 (ESTIMATED)
- **Last updated:** 2025-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06484686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06484686, "An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06484686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*